The Indian government is tightening regulations in the healthcare sector to combat unethical practices by pharmaceuticals and ...

GSK announces an $800 million investment to develop a biopharmaceutical manufacturing and research hub in Upper Merion, ...

Viatris announces its acquisition of Pacira Biosciences for $1.65 billion, enhancing its offerings in non-opioid pain ...

The pharmaceutical lobby group, PhRMA, has initiated legal action against the Trump administration's new drug pricing model aimed at reducing costs in the Medicare program, claiming it exceeds the ...

This article explores the recent trends in India's compliance with the US FDA, highlighting improvements in inspection ...

Aurobindo Pharma's US subsidiary recalls over 1.1 lakh bottles of Acetaminophen due to consumer complaints about tablet ...

Dr Reddy's Laboratories has received a Form 483 from the FDA, citing two observations during a recent inspection of its ...

The National Pharmaceutical Pricing Authority caps trade margins on anti-cancer drugs at 30%, aiming to significantly reduce ...

The US FDA has raised safety flags over Newron Pharmaceuticals' schizophrenia drug, evenamide, identifying four patient deaths in clinical trials and leading to a clinical hold on new patient ...

Founded in 2019 as Entos, Iambic is advancing a pipeline of drug candidates developed using its AI platform to treat solid ...

The Union Health Ministry plans to ban the promotion of prescription drugs at pharmacies to curb misuse and ensure patient ...

India's apex drug regulator announces focused audits for cough syrup manufacturing units to ensure quality compliance, citing past incidents of contamination and child deaths. Stringent actions will ...